Concepedia

Wesley Lebel

WL

Statistics

Publications

6

Citations

1.1K

H-Index

6

Active since

1980

Affiliations

Pfizer (United States)(Current)

Wesley Lebel is an author at Pfizer (United States) specializing in medicine, physiology, and pharmacology.

Top concepts

Publications per year

1980–2007

6

Publications

6

A Potent Nonpeptide Antagonist of the Substance P (NK <sub>1</sub> ) Receptor

R. Michael Snider, Jay W. Constantine, John Lowe et al. · Science · 1991 · 864 citations

, , +12

Inhibitory Effects of Antipsychotics on Carbachol-Enhanced Insulin Secretion From Perifused Rat Islets

David E. Johnson, Hanae Yamazaki, Karen Ward et al. · Diabetes · 2005 · 129 citations · Full text

Complete blockade by phenoxybenzamine of ?1- but not of ?2-vascular receptors in dogs and the effects of propranolol

Jay W. Constantine, Wesley Lebel · Naunyn-Schmiedeberg s Archives of Pharmacology · 1980 · 60 citations

, , +8

Functional postsynaptic α2- but not α1-adrenoceptors in dog saphenous vein exposed to phenoxybenzamine

Jay W. Constantine, Wesley Lebel, Robert Archer · European Journal of Pharmacology · 1982 · 56 citations

, , +6

Cardiovascular effects of CP-96,345, a non-peptide blocker of tachykinin NK1 receptors

Jay W. Constantine, Wesley Lebel, Heidi A. Woody et al. · European Journal of Pharmacology · 1994 · 17 citations

, , +11

1–5 of 6